Strategic Funding Led by Plains Ventures
In a recent funding round, Plains Ventures took the lead, securing support from notable investors such as the Oklahoma Life Science Fund, Cortado Ventures, Boyd Street Ventures, and Illinois Ventures.
Focused Investment for Therapeutic Advancements
The funds acquired are earmarked for a specific and critical cause—Cadenza Bio aims to channel the financial infusion into the development of therapeutic drugs with a primary focus on promoting remyelination in Multiple Sclerosis.
CEO Carol Curtis Guides Cadenza Bio’s Mission
Under the leadership of CEO Carol Curtis, Cadenza Bio is at the forefront of accelerating and facilitating the development of a series of groundbreaking Estrogen Receptor β (ERβ) targeting small-molecule compounds. The company is deeply committed to advancing therapeutic drugs that hold the potential to significantly improve the quality of life for individuals grappling with debilitating diseases.
Origins and Collaborative Research Impact
Established in 2022, Cadenza Bio emerged as a result of a collaboration between SmartHealth Catalyzer in Chicago and Ascend BioVentures in Oklahoma City.
The company holds an exclusive license for technology that originated from a collaborative academic research effort involving Dr. John Katzenellenbogen of the University of Illinois Urbana-Champaign (UIUC) and Dr. Seema Tiwari-Woodruff of the University of California, Riverside (UCR).
This research endeavor was partially funded by the National Multiple Sclerosis Society’s Fast Forward commercial research program.
Share on Facebook «||»
Share on Twitter «||»
Share on Reddit «||»
Share on LinkedIn
The Importance of Early Diagnosis and Treatment for Multiple Sclerosis: Post Preview The symptoms of multiple sclerosis are like a chameleon—they can mimic many other conditions. That’s one of the reasons it can take so...
Axelspace Secures $44M in Series D Funding to Propel Micro-Satellite Technology Expansion: Axelspace, a prominent player in micro-satellite technology, has successfully garnered support from a consortium of backers in its latest funding round. Notable contributors include Sumitomo...
Christina Applegate Gets Candid About Multiple Sclerosis, Emmy Awards, and Life’s Challenges: Christina Applegate, diagnosed with multiple sclerosis, candidly discusses the challenges she faces, revealing the intense anxiety she experienced during the Emmy Awards where she presented...
Christina Applegate Gets Emotional Discussing Multiple Sclerosis Diagnosis and Impact on Her Life During Exclusive Interview with Good Morning America’s Robin Roberts: Actress Christina Applegate becomes emotional as she opens up about her battle with multiple sclerosis during an exclusive interview with Robin Roberts on Good Morning...
MS Nightmare Unfolds: Bride’s Post-Hen-Do “Hangover” Turns Out to Be Early Signs of Multiple Sclerosis: Emily McColgan-Upfold shares her journey from celebration to diagnosis, as what seemed like a typical hangover following her hen-do turned out to be the early...
AlensiaXR Secures Series A Funding to Accelerate Advancements in HoloAnatomy® Learning Platform: In a recent funding round, AlensiaXR has successfully secured significant investments, with Sopris Capital at the forefront, accompanied by contributions from the Healthcare Collaboration Fund...
Nauticus Robotics Secures $12M in Funding From Unnamed Backers for Autonomous Ocean Robotics Advancements: In a recent development, Nauticus Robotics, the visionary company in the realm of autonomous ocean robotics, has successfully garnered funding from undisclosed backers. This financial...
2Africa Subsea Cable Reaches Nigerian Shores, Spearheading Digital Transformation: Enhanced Connectivity for Economic Prosperity With its capacity to connect 32 African countries, the 2Africa project is poised to drive economic development across the continent....
Revolutionizing Healthcare with Generative AI: Advancements in Diagnosis and Treatment: Artificial intelligence. It’s an innovation that took the world by storm, and many industries are now learning how to leverage its power. It made huge...
Strategic Investment of €2M to Fuels HEPHAISTOS’ Advancements in Oncology Treatment: Co-Leadership by xista science ventures and Foundation Fournier-Majoie: In a significant development, HEPHAISTOS, under the leadership of CEO Frederic Caroff, has successfully secured a strategic...